2.70

0.00% 0.00

After Hours: 2.72 0.02 +0.74%

Cronos Group Inc (CRON)

Overview News Price History Option Chain Financials Discussions Forecast

Cronos Group Inc stock is traded at $2.70, with a volume of 1.21M. It is up +0.00% in the last 24 hours and up +5.88% over the past month. Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Previous Close:

$2.70

Open:

$2.7

24h Volume:

1.21M

Relative Volume:

0.56

Market Cap:

$1.03B

Revenue:

$87.89M

Net Income/Loss:

$-73.96M

P/E Ratio:

-14.65

EPS:

-0.1843

Net Cash Flow:

$-46.26M

1W Performance:

+3.85%

1M Performance:

+5.88%

6M Performance:

+11.57%

1Y Performance:

+39.18%

1-Day Range:

$2.68

$2.7373

1-Week Range:

$2.5825

$2.7373

52-Week Range:

$1.60

$3.43

Cronos Group Inc Stock (CRON) Company Profile

Name

Cronos Group Inc

Sector

Healthcare (1108)

Industry

Drug Manufacturers - Specialty & Generic (82)

Phone

(416) 504-0004

Address

4491 CONCESSION RD 12, STAYNER, ON

Employee

459

Twitter

@cronosgroup

Next Earnings Date

2024-11-12

Latest SEC Filings

CRON's Discussions on Twitter

Compare CRON vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRON Cronos Group Inc	2.70	1.03B	87.89M	-73.96M	-46.26M	-0.1843
TAK Takeda Pharmaceutical Co Adr	18.66	58.95B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	128.78	53.73B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	11.27	49.47B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	34.22	39.98B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	473.42	20.69B	3.13B	1.27B	1.12B	26.39

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-27-26	Initiated	Canaccord Genuity	Buy
Nov-02-22	Initiated	Bernstein	Mkt Perform
Jul-28-22	Upgrade	Canaccord Genuity	Hold → Buy
May-11-22	Upgrade	CIBC	Neutral → Sector Outperform
Mar-22-22	Upgrade	Barclays	Underweight → Equal Weight
Jan-27-22	Upgrade	Jefferies	Underperform → Hold
Nov-18-21	Resumed	BofA Securities	Underperform
Apr-28-21	Resumed	BofA Securities	Underperform
Feb-22-21	Downgrade	CIBC	Sector Outperform → Neutral
Jun-24-20	Upgrade	Raymond James	Mkt Perform → Outperform
Apr-27-20	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-14-20	Downgrade	Piper Sandler	Overweight → Neutral
Apr-02-20	Downgrade	BofA/Merrill	Buy → Neutral
Mar-31-20	Downgrade	Canaccord Genuity	Hold → Sell
Mar-04-20	Upgrade	MKM Partners	Neutral → Buy
Mar-03-20	Downgrade	Stifel	Buy → Hold
Oct-18-19	Upgrade	Stifel	Hold → Buy
Sep-20-19	Initiated	MKM Partners	Neutral
Sep-05-19	Upgrade	BMO Capital Markets	Underperform → Market Perform
Aug-13-19	Initiated	Piper Jaffray	Overweight
Aug-09-19	Upgrade	Canaccord Genuity	Sell → Hold
Jun-28-19	Initiated	Consumer Edge Research	Equal Weight
Jun-06-19	Initiated	Stifel	Hold
Jun-05-19	Upgrade	BofA/Merrill	Underperform → Buy
Apr-17-19	Initiated	BofA/Merrill	Underperform
Mar-27-19	Downgrade	Canaccord Genuity	Hold → Sell
Feb-25-19	Initiated	Jefferies	Underperform
Jan-18-19	Initiated	CIBC	Sector Outperform

View All

Cronos Group Inc Stock (CRON) Latest News

Feb 21, 2026

Growth Report: Will Cronos Group Inc benefit from seasonalityJuly 2025 Retail & Technical Pattern Based Buy Signals - baoquankhu1.vn

Feb 21, 2026